Treatment

JNJ-89853413 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1
A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
This study is testing a new drug, JNJ-89853413, for people in the UK with certain types of blood cancer (relapsed or refractory AML or MDS) that haven't responded well to previous treatments. It aims to find a safe dose and see how well it works.
For: Leukemia, Myeloid, Acute · Myelodysplastic Neoplasms
Canada · Spain · United Kingdom